OIRM announces Accelerator Fund and Postdoctoral Fellowship Award recipients

Three new Accelerator Fund grants awarded

The Disease Team grant competition in late 2015 brought a number of very strong applications from across Ontario, of which four received funding (see annoucement). However, due to the strength and future potential of several non-funded applications, the international review panel convened by OIRM recommended that they be invited to compete in a new grant category, the Accelerator Fund. This new fund awards $100,000 for one year to help research programs advance and become better positioned for full Disease Team funding in a future round. After evaluation by the review panel the following three projects were awarded the Accelerator Fund grant:

  • Preclinical evaluation of a bioengineered human islet - Cristina Nostro (University Health Network)
  • Overcoming central vision loss with stem cell therapy and rehabilitation - Valerie Wallace (University Health Network)
  • Pluripotent and cord blood derived progenitor T-cells for immune reconstitution therapy - Juan-Carlos Zúñiga-Pflücker (Sunnybrook Research Institute)


Two Postdoctoral Fellowships awarded (co-sponsored by OIRM and Medicine by Design)

OIRM received 22 applications for Postdoctoral Fellowship awards. After careful evaluation by the review panel, two applicants were selected; each awardee will be co-sponsored by OIRM and Medicine by Design. Congratulations to both awardees:

  • Jeff Harding, Lunenfeld-Tanenbaum Research Institute (Andras Nagy lab), working on local ON/OFF control of tolerance toward allograft cell transplants
  • Vladimir Manchev, University Health Network (Gordon Keller lab), working on dissecting the role of Notch signalling during the transition from HE to HSC.